130 related articles for article (PubMed ID: 6175567)
1. Potentiation of natural killer cell activity of human lymphocytes in vitro: the participation of interferon in stimulation with Staphylococcus aureus Cowan I bacteria but not with protein A.
Kasahara T; Harada H; Shioiri-Nakano K; Wakasugi H; Imai M; Mayumi M; Sano T; Sugiura A
Immunology; 1982 Apr; 45(4):687-95. PubMed ID: 6175567
[TBL] [Abstract][Full Text] [Related]
2. Potentiation of natural killer activity of human lymphocytes by Staphylococcus aureus bacteria and its protein A.
Kasahara T; Harada H; Shioiri-Nakano K; Imai M; Sano T
Immunology; 1981 Feb; 42(2):175-83. PubMed ID: 6161884
[TBL] [Abstract][Full Text] [Related]
3. Surface immunoglobulins are involved in the interaction of protein A with human B cells and in the triggering of B cell proliferation induced by protein A-containing Staphylococcus aureus.
Romagnani S; Giudizi MG; Biagiotti R; Almerigogna F; Maggi E; Del Prete G; Ricci M
J Immunol; 1981 Oct; 127(4):1307-13. PubMed ID: 6974188
[TBL] [Abstract][Full Text] [Related]
4. In vitro potentiation of human natural killer cell activity by a streptococcal preparation, OK-432: interferon and interleukin-2 participation in the stimulation with OK-432.
Wakasugi H; Kasahara T; Minato N; Hamuro J; Miyata M; Morioka Y
J Natl Cancer Inst; 1982 Oct; 69(4):807-12. PubMed ID: 6181282
[TBL] [Abstract][Full Text] [Related]
5. Regulation of natural killer cytotoxicity by recombinant alpha interferons. Augmentation by IFN-alpha 7, an interferon similar to IFN-alpha J.
Platsoucas CD; Fox FE; Oleszak E; Fong K; Nanno M; Ioannides CG; Trotta PP
Anticancer Res; 1989; 9(4):849-58. PubMed ID: 2817813
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcus aureus protein A induces the production of interferon-alpha in human lymphocytes and interferon-alpha/beta in mouse spleen cells.
Smith EM; Johnson HM; Blalock JE
J Immunol; 1983 Feb; 130(2):773-6. PubMed ID: 6401305
[TBL] [Abstract][Full Text] [Related]
7. Effect of Staphylococcus aureus Cowan i bacteria on the mitogenic response of human B-cell subsets.
Harada H; Kasahara T; Ogata K; Shioiri-Nakano K; Kawai T
Immunology; 1982 Nov; 47(3):557-67. PubMed ID: 6982223
[TBL] [Abstract][Full Text] [Related]
8. Studies on the mechanism of natural killer cytotoxicity. III. Activation of NK cells by interferon augments the lytic activity of released natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2960-4. PubMed ID: 6189908
[TBL] [Abstract][Full Text] [Related]
9. [Changes caused by staphylococcal protein A and gamma interferon on the natural cytotoxic activity in patients with cancer].
Subirá ML; Sánchez-Ibarrola A
Rev Esp Fisiol; 1989; 45 Suppl():239-44. PubMed ID: 2518334
[TBL] [Abstract][Full Text] [Related]
10. Antibody to staphylococcal enterotoxin A-induced human immune interferon (IFN gamma).
Langford MP; Weigent DA; Georgiades JA; Johnson HM; Stanton GJ
J Immunol; 1981 Apr; 126(4):1620-3. PubMed ID: 6162895
[TBL] [Abstract][Full Text] [Related]
11. Rapid induction of seven proteins in human lymphocytes by interferon; correlation to natural killer cell activity.
Gustafsson A; Sundström S; Ny T; Lundgren E
J Immunol; 1982 Nov; 129(5):1952-9. PubMed ID: 6181151
[TBL] [Abstract][Full Text] [Related]
12. Systemic administration of human leukocyte interferon to melanoma patients. II. Cellular events associated with changes in natural killer cytotoxicity.
Golub SH; D'Amore P; Rainey M
J Natl Cancer Inst; 1982 May; 68(5):711-7. PubMed ID: 6175788
[TBL] [Abstract][Full Text] [Related]
13. Role of interferon in augmentation of natural and antibody-dependent cell-mediated cytotoxicity.
Herberman RB; Djeu JY; Ortaldo JR; Holden HT; West WH; Bonnard GD
Cancer Treat Rep; 1978 Nov; 62(11):1893-6. PubMed ID: 728907
[TBL] [Abstract][Full Text] [Related]
14. Distinction of two subtypes of human leukocyte interferon (IFN-alpha) on B cell activation. B cell proliferation by two subtypes of IFN-alpha.
Harada H; Shioiri-Nakano K; Mayumi M; Kawai T
J Immunol; 1983 Jul; 131(1):238-43. PubMed ID: 6602831
[TBL] [Abstract][Full Text] [Related]
15. Modulation of murine natural killer cell activity in vitro and in vivo by recombinant human interferons.
Brunda MJ; Rosenbaum D
Cancer Res; 1984 Feb; 44(2):597-601. PubMed ID: 6692364
[TBL] [Abstract][Full Text] [Related]
16. Studies on the mechanism of natural killer cell-mediated cytotoxicity. IV. Interferon-induced inhibition of NK target cell susceptibility to lysis is due to a defect in their ability to stimulate release of natural killer cytotoxic factors (NKCF).
Wright SC; Bonavida B
J Immunol; 1983 Jun; 130(6):2965-8. PubMed ID: 6189909
[TBL] [Abstract][Full Text] [Related]
17. Effects of natural and recombinant IL 2 on regulation of IFN gamma production and natural killer activity: lack of involvement of the Tac antigen for these immunoregulatory effects.
Ortaldo JR; Mason AT; Gerard JP; Henderson LE; Farrar W; Hopkins RF; Herberman RB; Rabin H
J Immunol; 1984 Aug; 133(2):779-83. PubMed ID: 6203980
[TBL] [Abstract][Full Text] [Related]
18. Role of interferon in natural kill of HSV-1-infected fibroblasts.
Fitzgerald PA; von Wussow P; Lopez C
J Immunol; 1982 Aug; 129(2):819-23. PubMed ID: 6177785
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cell function in trisomy-21 (Down's syndrome).
Nurmi T; Huttunen K; Lassila O; Henttonen M; Säkkinen A; Linna SL; Tiilikainen A
Clin Exp Immunol; 1982 Mar; 47(3):735-41. PubMed ID: 6177458
[TBL] [Abstract][Full Text] [Related]
20. Analysis of natural killer cell cytotoxicity of cancer patients treated with recombinant interferon.
Lotzová E; Savary CA; Quesada JR; Gutterman JU; Hersh EM
J Natl Cancer Inst; 1983 Nov; 71(5):903-10. PubMed ID: 6580490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
